| scholarly article | Q13442814 |
| P50 | author | Arwyn T. Jones | Q40328792 |
| P2093 | author name string | Shiroh Futaki | |
| Ikuhiko Nakase | |||
| Toshihide Takeuchi | |||
| Michie Kosuge | |||
| P433 | issue | 3 | |
| P304 | page(s) | 656-664 | |
| P577 | publication date | 2008-02-13 | |
| P1433 | published in | Bioconjugate Chemistry | Q2343023 |
| P1476 | title | Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans | |
| P478 | volume | 19 |
| Q64976300 | A Biomimetic Chitosan Derivates: Preparation, Characterization and Transdermal Enhancement Studies of N-Arginine Chitosan |
| Q42952023 | A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. |
| Q48063119 | A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors. |
| Q41940806 | Adenosine-oligoarginine conjugate, a novel bisubstrate inhibitor, effectively dissociates the actin cytoskeleton |
| Q33877242 | An Amino Acid-based Amphoteric Liposomal Delivery System for Systemic Administration of siRNA |
| Q84112458 | Arginine-rich CPPs for improved drug delivery to tumors |
| Q42262589 | Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery |
| Q39245922 | Avidin–Biotin Interaction Mediated Peptide Assemblies as Efficient Gene Delivery Vectors for Cancer Therapy |
| Q39649638 | Bactenecin 7 peptide fragment as a tool for intracellular delivery of a phosphorescent oxygen sensor |
| Q38328095 | Bio-conjugation of antioxidant peptide on surface-modified gold nanoparticles: a novel approach to enhance the radical scavenging property in cancer cell |
| Q38087759 | Bioinspired peptides as versatile nucleic acid delivery platforms |
| Q42255378 | Breaking in and busting out: cell-penetrating peptides and the endosomal escape problem. |
| Q61799189 | CGA-N9, an antimicrobial peptide derived from chromogranin A: direct cell penetration of and endocytosis by |
| Q38495028 | Cationic cell-penetrating peptides as vehicles for siRNA delivery |
| Q36208782 | Cationic polyfluorenes for intracellular delivery of proteins |
| Q58778516 | Cell Penetration Profiling Using the Chloroalkane Penetration Assay |
| Q39629419 | Cell line-dependent internalization pathways determine DNA transfection efficiency of decaarginine-PEG-lipid |
| Q38622635 | Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals |
| Q38073082 | Cell-penetrating peptides (CPPs) as a vector for the delivery of siRNAs into cells. |
| Q34215571 | Cell-penetrating peptides: classes, origin, and current landscape |
| Q42204202 | Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription. |
| Q39502685 | Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis |
| Q46020319 | Cellular uptake of octaarginine-conjugated tetraarylporphyrin included by per-O-methylated β-cyclodextrin. |
| Q33742595 | Cellular uptake of ribonuclease A relies on anionic glycans |
| Q37059828 | Cell‐Penetrating Peptides as Delivery Vehicles for a Protein‐Targeted Terbium Complex |
| Q39470764 | Co-operative Membrane Disruption Between Cell-penetrating Peptide and Cargo: Implications for the Therapeutic Use of the Bcl-2 Converter Peptide D-NuBCP-9-r8 |
| Q51064863 | Collagen-like cell-penetrating peptides. |
| Q54991036 | Contrasting roles for actin in the cellular uptake of cell penetrating peptide conjugates. |
| Q39558825 | Contributions of Glycosaminoglycan Binding and Clustering to the Biological Uptake of the Nonamphipathic Cell-Penetrating Peptide WR9 |
| Q47810720 | Convergent synthesis and cellular uptake of multivalent cell penetrating peptides derived from Tat, Antp, pVEC, TP10 and SAP. |
| Q41445064 | Cytoplasmic delivery and selective, multicomponent labeling with oligoarginine-linked protein tags |
| Q55435441 | Design and biological characterization of novel cell-penetrating peptides preferentially targeting cell nuclei and subnuclear regions. |
| Q97553979 | Design and investigation of penetrating mechanism of octaarginine-modified alginate nanoparticles for improving intestinal insulin delivery |
| Q50240213 | Detecting Cytosolic Peptide Delivery with the GFP Complementation Assay in the Low Micromolar Range. |
| Q92703678 | Development of Organelle Replacement Therapy Using a Stearyl-Polyhistidine Peptide against Lysosomal Storage Disease Cells |
| Q41050184 | Development of a Cell-penetrating Peptide that Exhibits Responsive Changes in its Secondary Structure in the Cellular Environment. |
| Q54943714 | Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands. |
| Q51754389 | Different roles of cell surface and exogenous glycosaminoglycans in controlling gene delivery by arginine-rich peptides with varied distribution of arginines |
| Q39489932 | Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells |
| Q42552744 | Do Cell-Penetrating Peptides Actually “Penetrate” Cellular Membranes? |
| Q34742458 | Effects of pyrenebutyrate on the translocation of arginine-rich cell-penetrating peptides through artificial membranes: Recruiting peptides to the membranes, dissipating liquid-ordered phases, and inducing curvature |
| Q35740804 | Effects of the properties of short peptides conjugated with cell-penetrating peptides on their internalization into cells |
| Q53195109 | Efficient Intracellular Delivery of Nucleic Acid Pharmaceuticals Using Cell-Penetrating Peptides |
| Q100681457 | Efficient LRP1-mediated uptake and low cytotoxicity of peptide L57 in vitro shows its promise as CNS drug delivery vector |
| Q36184677 | Efficient entry of cell-penetrating peptide nona-arginine into adherent cells involves a transient increase in intracellular calcium |
| Q38898870 | Elastin-like recombinamers with acquired functionalities for gene-delivery applications. |
| Q35679874 | Electrochemical impedimetric biosensor based on a nanostructured polycarbonate substrate |
| Q88611552 | Emerging Methods and Design Principles for Cell-Penetrant Peptides |
| Q34806459 | Endocytic Trafficking of Nanoparticles Delivered by Cell-penetrating Peptides Comprised of Nona-arginine and a Penetration Accelerating Sequence |
| Q39145986 | Enhancing Effect of Poly(amino acid)s on Albumin Uptake in Human Lung Epithelial A549 Cells |
| Q42823027 | Evaluation of Cell-Penetrating Peptide/Adenovirus Particles for Transduction of CAR-Negative Cells |
| Q34998244 | Exogenous and Cell Surface Glycosaminoglycans Alter DNA Delivery Efficiency of Arginine and Lysine Homopeptides in Distinctly Different Ways |
| Q41888646 | Fluorescein redirects a ruthenium-octaarginine conjugate to the nucleus |
| Q38707068 | Glycosaminoglycan Binding and Non-Endocytic Membrane Translocation of Cell-Permeable Octaarginine Monitored by Real-Time In-Cell NMR Spectroscopy |
| Q27355524 | How to unveil self-quenched fluorophores and subsequently map the subcellular distribution of exogenous peptides |
| Q84033281 | Identification and characterization of anti-osteoclastogenic peptides derived from the cytoplasmic tail of receptor activator of nuclear factor kappa B |
| Q91828122 | Impact Of Penetratin Stereochemistry On The Oral Bioavailability Of Insulin-Loaded Solid Lipid Nanoparticles |
| Q37277330 | Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges |
| Q38995503 | In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice |
| Q39382518 | Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells |
| Q33577349 | Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers |
| Q34749523 | Intracellular Delivery of Nanoparticles and DNAs by IR9 Cell-penetrating Peptides |
| Q39352854 | Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. |
| Q30847165 | Investigating Engineered Ribonucleoprotein Particles to Improve Oral RNAi Delivery in Crop Insect Pests. |
| Q38129998 | Is there a future for cell-penetrating peptides in oligonucleotide delivery? |
| Q37621506 | Lanthanide-based imaging of protein-protein interactions in live cells |
| Q48034399 | Loosening of Lipid Packing Promotes Oligoarginine Entry into Cells. |
| Q39884008 | Low concentration thresholds of plasma membranes for rapid energy-independent translocation of a cell-penetrating peptide |
| Q21296784 | Mechanisms of cellular uptake of cell-penetrating peptides |
| Q36778764 | Membrane Oxidation Enables the Cytosolic Entry of Polyarginine Cell-penetrating Peptides |
| Q39206760 | Membrane Oxidation in Cell Delivery and Cell Killing Applications. |
| Q34649007 | Modeling of the endosomolytic activity of HA2-TAT peptides with red blood cells and ghosts. |
| Q39255968 | Nanoscale Biodegradable Organic-Inorganic Hybrids for Efficient Cell Penetration and Drug Delivery |
| Q39429345 | Novel Cell‐Penetrating Peptides Based on α‐Aminoxy Acids |
| Q38272001 | Peptide-based vectors: recent developments. |
| Q41845396 | Relating structure and internalization for ROMP-based protein mimics |
| Q53230602 | Self-Assembled Fluorescent Nanoparticles from π-Conjugated Small Molecules: En Route to Biological Applications |
| Q44448702 | Self-assembled fluorescent organic nanoparticles for live-cell imaging |
| Q87374750 | Structural and Thermodynamic Insight into Spontaneous Membrane-Translocating Peptides Across Model PC/PG Lipid Bilayers |
| Q53345225 | Supramolecular intracellular delivery of an anionic porphyrin by octaarginine-conjugated per-O-methyl-β-cyclodextrin |
| Q39761178 | Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides |
| Q34818576 | Targeting acute myeloid leukemia with a proapoptotic peptide conjugated to a Toll-like receptor 2-mediated cell-penetrating peptide. |
| Q37811739 | Targeting antibodies to the cytoplasm |
| Q38340819 | The Pharmacokinetics of Cell-Penetrating Peptides |
| Q92825203 | The Utilization of Cell-Penetrating Peptides in the Intracellular Delivery of Viral Nanoparticles |
| Q30481368 | The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis |
| Q92527298 | The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection |
| Q35939416 | Transient focal membrane deformation induced by arginine-rich peptides leads to their direct penetration into cells. |
| Q92434851 | Trapped! A Critical Evaluation of Methods for Measuring Total Cellular Uptake versus Cytosolic Localization |
| Q64319564 | Tunable Membrane Potential Reconstituted in Giant Vesicles Promotes Permeation of Cationic Peptides at Nanomolar Concentrations |
| Q47728958 | Unlocking Endosomal Entrapment with Supercharged Arginine-Rich Peptides |
| Q60923739 | Versatility of cell-penetrating peptides for intracellular delivery of siRNA |
| Q92824512 | pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theranostic Applications |
Search more.